Samenvatting
Despite its success in multiple tumor types, immunotherapy remains poorly efficacious in brain malignancies. In this issue of Cell, Friebel et al. and Klemm et al. provide in-depth insights into the versatile nuances of immune cells in primary and metastatic brain tumors, granting the field with a rich framework to explore novel therapeutic avenues.
| Originele taal-2 | Engels |
|---|---|
| Pagina's (van-tot) | 1454-1457 |
| Aantal pagina's | 4 |
| Tijdschrift | Cell |
| Volume | 181 |
| Nummer van het tijdschrift | 7 |
| DOI's | |
| Status | Gepubliceerd - 25 jun. 2020 |